Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Expected to Post Quarterly Sales of $4.77 Million

Retrieved on: 2021-01-02 10:52:22

Tags for this article:

Click the tags to see associated articles and topics

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Expected to Post Quarterly Sales of $4.77 Million. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.74) EPS for the quarter, missing the Zacks' consensus estimate of ($0.60) by ($0.14). The firm had revenue ...

Article found on: www.marketbeat.com